L-tert.Leucine

L-tert.Leucine is the L-configured, branched-chain amino acid bearing a tert-butyl-substituted side chain that increases steric bulk relative to leucine while preserving the canonical amino acid framework. The molecule contains a free or derivatizable α-amino functionality and an α-carboxylic acid (depending on the supplied form), enabling standard peptide coupling chemistry and downstream transformation into protected amino acid derivatives. The stereogenic center at the α-position provides defined chiral recognition in synthesis and in stereoselective incorporation into peptide scaffolds. The tert-butyl-like side chain is chemically stable under many peptide-manipulation conditions and can serve as a hydrophobic handle for tuning conformational behavior, solubility, and binding-site interactions in peptide and peptidomimetic design.

1. Peptide Synthesis

L-tert.Leucine is applied in peptide building block preparation for solid-phase and solution-phase peptide synthesis workflows where a chiral, hydrophobic amino acid residue is required. The α-amino and α-carboxyl functionalities support formation of amide bonds after conversion to an appropriate N-protected amino acid derivative and activation of the carboxyl group during peptide coupling. The L-stereochemistry enables stereochemically consistent incorporation into growing peptide chains, while the tert-leucine side chain provides steric modulation that can influence helix propensity and local backbone packing. L-tert.Leucine-derived residues can be used to generate peptide analogs for structure-activity relationship studies and to prepare libraries of hydrophobic variants for synthetic screening. Downstream deprotection and fragment coupling strategies can leverage the side-chain stability to maintain residue integrity through iterative peptide assembly.

2. Amino Acid Derivatization

L-tert.Leucine is suitable for amino acid derivatization and chiral intermediate construction where functional group transformations of the α-carboxyl or α-amino groups are needed for downstream synthesis. The amino acid backbone can be converted into esters, amides, or activated intermediates to support controlled reactivity in process chemistry and fine chemical synthesis. The bulky tert-leucine side chain can be retained during derivatization to introduce hydrophobic character into target molecules, including enzyme-binding motifs and synthetic substrates. The defined L-configuration helps maintain stereochemical fidelity across multi-step routes that require preservation of the α-stereocenter. Resulting derivatives can serve as intermediates for further side-chain functionalization strategies or as protected amino acid inputs for iterative scaffold diversification.

3. Peptidomimetics And SAR

L-tert.Leucine supports peptidomimetic construction and structure-activity relationship studies by providing a sterically demanding, hydrophobic residue that can mimic or modulate the spatial presentation of side-chain bulk in bioactive peptide-like structures. The α-amino acid core enables incorporation into constrained frameworks or replacement of native residues in analog design, while the tert-leucine side chain can tune conformational preferences and interaction patterns through steric and hydrophobic effects. The stable side chain can be maintained during synthesis of analogs that undergo backbone modifications, N-terminus or C-terminus capping, and selective deprotection sequences. The resulting L-tert.Leucine-containing scaffolds can be used to generate SAR-focused series that probe the role of hydrophobic volume and stereochemical context in molecular recognition. Amino acid chemistry compatibility makes it amenable to both fragment assembly and late-stage coupling strategies used in medicinal chemistry research.

4. Protein Engineering

L-tert.Leucine is applicable to protein engineering and chemical biology workflows that require defined incorporation of hydrophobic amino acid residues into peptide or protein constructs. The L-chiral amino acid structure can be used as a residue analog in peptide segments that are later assembled into larger biomolecular architectures or used as reference standards for labeling and binding studies. The tert-leucine side chain contributes steric bulk and hydrophobic character that can affect local folding, aggregation propensity, and interaction surfaces in engineered peptide domains. The α-amino acid functionality enables attachment to N- or C-terminal modifications through standard peptide coupling and terminal capping chemistry. L-tert.Leucine-containing constructs can therefore function as controlled stereochemical probes for studying sequence-dependent behavior in biomolecular systems.

5. Pharmaceutical Intermediate Preparation

L-tert.Leucine can be employed in pharmaceutical intermediate preparation where chiral amino acid derivatives are required for manufacturing routes toward peptide-like active ingredients, chiral auxiliaries, or process intermediates. The amino acid backbone provides a handle for conversion to protected amino acid derivatives, activated esters, or amide-forming intermediates that can be integrated into larger synthetic sequences under controlled reactivity. The sterically bulky, hydrophobic side chain can be carried through intermediate stages to maintain the desired steric profile of the target scaffold. L-stereochemistry supports stereochemically defined downstream transformations, reducing risk of racemization during protection, coupling, and deprotection steps. Industrially relevant synthesis planning can leverage the chemical robustness of the tert-leucine side chain to support consistent intermediate formation for fine chemical production and specialty manufacturing.

6. Analytical Research Standards

L-tert.Leucine is suitable for analytical research and method development where amino acid standards, chiral reference materials, or peptide hydrolysis controls are required. The well-defined L-configuration and characteristic branched hydrophobic side chain enable unambiguous identification in chromatographic and mass spectrometric analyses when used as a reference analyte. Derivatives prepared from L-tert.Leucine, including protected forms or labeled analogs, can be used to validate derivatization efficiency and to monitor amino acid integrity after peptide coupling and deprotection sequences. The α-amino acid framework supports conversion into common analytical forms used for quantitation and identity confirmation. Incorporation into peptide standards also enables method verification for peptide construction workflows and for downstream quality control of amino acid-derived intermediates.

1. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics

2. Emu oil in combination with other active ingredients for treating skin imperfections

3. The spatiotemporal control of signalling and trafficking of the GLP-1R

4. GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats

5. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes